Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots"
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (5), 825-830
- https://doi.org/10.1038/s41436-019-0740-6
Abstract
No abstract availableFunding Information
- National Institutes of Health (1R35 CA197458)
- Susan G. Komen (SAC110020;)
This publication has 38 references indexed in Scilit:
- A High-Throughput Functional Complementation Assay for Classification ofBRCA1Missense VariantsCancer Discovery, 2013
- A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair ActivityCancer Research, 2013
- Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico PredictionPLOS ONE, 2012
- The next controversy in genetic testing: clinical data as trade secrets?European Journal of Human Genetics, 2012
- Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicingBreast Cancer Research and Treatment, 2011
- Comprehensive Analysis of Missense Variations in the BRCT Domain of BRCA1 by Structural and Functional AssaysCancer Research, 2010
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 2009
- The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on lifePsycho‐Oncology, 2008
- Spectrum and characterisation of BRCA1 and BRCA2deleterious mutations in high-risk Czech patients with breast and/or ovarian cancerBMC Cancer, 2008
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004